作者: Ian Cottingham , Niclas Axel Petri
DOI:
关键词:
摘要: A selective IL-6- trans -signalling inhibitor can be used to treat a variety of mediated conditions, including inflammatory diseases and cancer. The safely administered humans at doses. Moreover, the lessens deleterious effects associated with other IL-6 inhibitors such as lowering neutrophil counts, platelet counts levels C-reactive protein.